Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001415889-25-018804
Filing Date
2025-07-01
Accepted
2025-07-01 19:33:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3126
  Complete submission text file 0001415889-25-018804.txt   4663
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39503 | Film No.: 251097977
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ATHIRA PHARMA, INC. 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address
Worthington Mark (Reporting) CIK: 0001861464 (see all company filings)

Type: 144